Literature DB >> 4309452

Serological studies in infectious mononucleosis.

J E Banatvala, S G Grylls.   

Abstract

Serological investigations performed on 27 patients with illnesses resembling infectious mononucleosis showed a significant increase in high antibody titres (more than 1:40) to EB virus in 11 of the 12 who developed heterophile antibodies. Two of these patients, however, had a significant increase in antibody titre to cytomegalovirus and rubella virus, respectively. Of 15 patients who failed to develop heterophile antibodies, one had a high antibody titre to EB virus, the others generally having undetectable or low antibody titres. The insidious onset of the illness in many patients together with the fact that EB virus antibodies rose to high titres rapidly reduced the value of this investigation diagnostically.EB virus antibody was still present in the sera of five patients who had had well-authenticated heterophile-antibody-positive infectious mononucleosis some four to seven years previously. Twenty-seven out of 70 (39%) healthy nurses had antibody at a level of more than 1:10 to EB virus. The presence of EB virus antibody in different population groups appears to be related to such factors as age and socioeconomic status.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4309452      PMCID: PMC1984207          DOI: 10.1136/bmj.3.5668.444

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  11 in total

1.  VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.

Authors:  M A EPSTEIN; B G ACHONG; Y M BARR
Journal:  Lancet       Date:  1964-03-28       Impact factor: 79.321

2.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

3.  Further studies on cytomegalovirus mononucleosis in previously healthy individuals.

Authors:  E Klemola; L Kääriäinen; R von Essen; K Haltia; A Koivuniemi; C H von Bonsdorff
Journal:  Acta Med Scand       Date:  1967-09

4.  Immunofluorescence, interference, and complement fixation technics in the detection of the herpes-type virus in Burkitt tumor cell lines.

Authors:  G Henle; W Henle
Journal:  Cancer Res       Date:  1967-12       Impact factor: 12.701

5.  Serum IgM and IgG responses in postnatally acquired rubella.

Authors:  J M Best; J E Banatvala; D Watson
Journal:  Lancet       Date:  1969-07-12       Impact factor: 79.321

6.  Seroepidemiologic studies of infectious mononucleosis with EB virus.

Authors:  A S Evans; J C Niederman; R W McCollum
Journal:  N Engl J Med       Date:  1968-11-21       Impact factor: 91.245

7.  Infectious mononucleosis. Clinical manifestations in relation to EB virus antibodies.

Authors:  J C Niederman; R W McCollum; G Henle; W Henle
Journal:  JAMA       Date:  1968-01-15       Impact factor: 56.272

8.  Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis.

Authors:  G Henle; W Henle; V Diehl
Journal:  Proc Natl Acad Sci U S A       Date:  1968-01       Impact factor: 11.205

9.  Rubella-virus hemagglutination-inhibition test.

Authors:  G L Stewart; P D Parkman; H E Hopps; R D Douglas; J P Hamilton; H M Meyer
Journal:  N Engl J Med       Date:  1967-03-09       Impact factor: 91.245

10.  Demonstration of a herpes group virus in cultures of peripheral leukocytes from patients with infectious mononucleosis.

Authors:  V Diehl; G Henle; W Henle; G Kohn
Journal:  J Virol       Date:  1968-07       Impact factor: 5.103

View more
  3 in total

1.  Serological response of the EBV antibodies in pediatric cases of infectious mononucleosis and in their contacts.

Authors:  J Joncas; C Mitnyan
Journal:  Can Med Assoc J       Date:  1970-06-06       Impact factor: 8.262

2.  Serological studies in infectious mononucleosis.

Authors:  M G Mott
Journal:  Br Med J       Date:  1969-10-18

3.  IgM antibodies specific for Epstein-Barr virus in infectious mononucleosis without heterophil antibodies.

Authors:  J Nikoskelainen; J Leikola; E Klemola
Journal:  Br Med J       Date:  1974-10-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.